Ketamine derivative gets FDA approval for adjunct use in treatment-resistant major depressive disorder.
https://www.scientificamerican.com/article/fda-approves-esketamine-the-first-major-depression-treatment-to-reach-u-s-market-in-decades/
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.
